Triomics nabs $22M to bring oncology-specific AI to cancer centers
Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks like clinical trial matching and appointment prep, has raised $22 million in Series B funding.
The round was led by Battery Ventures, with participation from returning backers Nexus Venture Partners, Lightspeed, Y Combinator, and others.
The good news is that oncology breakthroughs are keeping patients alive longer. That welcome trend, however, is creating dense, multi-year medical records that take healthcare staff a long time to review and decipher.
A typical medical chart includes physician progress notes, imaging and pathology reports, and even scans of faxes. “We have seen medical records [with] thousands of pages of information,” Triomics co-founder Sarim Khan (pictured left) told TechCrunch.
Founded in 2021, the startup raised a $15 million in Series Ain mid-2024. Initially focused on helping doctors identify the most suitable clinical trials for their patients, Triomics...
Copyright of this story solely belongs to techcrunch.com. To see the full text click HERE
